Skip to main content

Colliers acquires Rome’s leading residential asset advisor

Enhances capabilities in development and urban regeneration projectsColliers acquires Progedil, Rome’s leading residential asset advisorColliers acquires Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects.ROME, March 02, 2026 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company Colliers announces the acquisition of Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects in one of Italy’s most dynamic residential markets. As part of the transaction, Progedil’s senior leadership team has retained significant equity in the business and will continue to lead the day-to-day operations.  Progedil provides full-service project marketing for residential...

Continue reading

Bitcoin Depot Expands Product Portfolio with Acquisition of Social Betting Platform, Kutt

Company Enters Peer-to-Peer Social Betting Market as Part of Broader Product Diversification Strategy ATLANTA, March 02, 2026 (GLOBE NEWSWIRE) — Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that it has acquired Kutt, a peer-to-peer (“P2P”) social betting platform that enables users to wager directly against each other on both private and publicly verifiable events. The acquisition marks Bitcoin Depot’s first entry into the P2P social betting market and reflects the Company’s broader strategy to diversify its product offerings beyond its core Bitcoin ATM business. Kutt’s platform is positioned within one of the fastest-growing segments of consumer fintech, as Americans wagered over $165 billion through U.S. sportsbooks in 2025, reflecting the continued expansion...

Continue reading

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

Acquisition will create a U.S.- and China-based fully integrated biopharmaceutical company with revenue-producing commercial assets and a robust pipeline of degraders, targeting inflammatory diseases and cancers. Access to degrader-antibody conjugates (DACs) platform technology for future discovery engine. Strengthened leadership team designed to support future global growth. Transaction is anticipated to close early in the second quarter of 2026. An updated corporate presentation has been posted to the Gyre and Cullgen websites.SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (Gyre or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, today announced its agreement to acquire...

Continue reading

Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement

TORONTO, March 02, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a global leader in photonic quantum computing, and Crane Harbor Acquisition Corp. (Nasdaq: CHAC) (“Crane Harbor”), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective the companies’ joint registration statement on Form F-4 in connection with their previously announced proposed business combination. This marks a significant milestone in the transaction process and moves Xanadu substantially closer to becoming a publicly traded company. The business combination is expected to close in the first quarter of 2026, subject to the satisfaction of customary closing conditions, including the approval by Crane Harbor and Xanadu shareholders and the listing...

Continue reading

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

HEMANGEOL® is the only FDA-approved treatment for infantile hemangioma HEMANGEOL will be commercialized by Eton beginning May 1st HEMANGEOL will be distributed through the company’s Eton Cares™ patient support program, which includes a $0 co-pay initiative, to broaden patient access.DEER PARK, Ill., March 02, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced it has in-licensed U.S. commercialization rights to HEMANGEOL® oral solution from Pierre Fabre Medicament Sas (“Pierre Fabre”). HEMANGEOL is an Orphan Drug indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. “As the only treatment for infantile hemangiomas that...

Continue reading

HBT Financial, Inc. Completes Merger with CNB Bank Shares, Inc.

BLOOMINGTON, Ill., March 02, 2026 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company (“Heartland Bank”), today announced that it has completed its merger with CNB Bank Shares, Inc. (“CNB”), the holding company for CNB Bank & Trust, N.A. (“CNB Bank”). At the effective time of the Merger, CNB merged with a wholly-owned subsidiary of HBT, with CNB surviving as a wholly-owned subsidiary of HBT. Immediately thereafter, CNB merged (the “Merger”) with and into HBT Financial, with HBT Financial surviving the Merger. In addition, following the Merger, CNB Bank, CNB’s wholly-owned bank subsidiary, merged with and into Heartland Bank, with Heartland Bank continuing as the surviving bank. As of December 31, 2025, CNB had $1.8 billion in...

Continue reading

CTO Realty Growth Announces Acquisition of Palms Crossing for $81.6 Million

WINTER PARK, Fla., March 02, 2026 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”), a leading owner and operator of high-quality, open-air shopping centers located in the higher growth Southeast and Southwest markets of the United States, today announced the acquisition of Palms Crossing (the “Property”), an open-air retail center consisting of 399,000 square feet for a purchase price of $81.6 million. Palms Crossing is currently 98% leased, anchored by Best Buy, Hobby Lobby, Burlington Coat Factory, Barnes & Noble and Nike. The Property is located on 47 acres in McAllen, Texas with a population of approximately 200,000 within a five-mile radius. Additionally, the Property features two pad sites situated on approximately six acres representing future development opportunities. With this acquisition,...

Continue reading

CSG Enters the Hungarian Defence Industry. To Participate in the Delivery of Thousands of Military Vehicles; Investment Plans Also Include Integration of HIMARS Systems at Rába

The global industrial and technology group CSG will acquire a 49% stake in 4iG Space & Defence Technologies, thereby also indirectly becoming a 37% shareholder in Rába Automotive Holding Plc. Through this transaction, the Group confirms its ambition to become a long-term strategic partner of the Hungarian defence industry. The initial investments also include signed contracts for the production and delivery of thousands of military vehicles, as well as potential participation in the HIMARS programme for Hungary. The follow-on industrial projects further develop the previously announced partnership between CSG, 4iG and Rába Automotive Holding and create a foundation for long-term investment, technology transfer and the systematic localisation of production in Hungary. These steps will strengthen not only the Hungarian but also the...

Continue reading

Zacatecas Silver Announces Agreement to Acquire Multi-Asset Exploration Portfolio from Heliostar Metals, Significantly Expanding Mexican Asset Base

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”) is pleased to announce that it has entered into a binding agreement with Heliostar Metals Ltd. (“Heliostar”) to acquire a 100 percent interest in the Cumaro, La Lola, Oso Negro and Ejutla exploration properties located in Sonora, and Oaxaca, Mexico (collectively, the “Exploration Portfolio”). The acquisition establishes a new district-scale exploration platform for the Company in a prolific mining jurisdiction and adds four high-impact discovery opportunities to Zacatecas Silver’s pipeline. The portfolio provides near-term drill targeting potential while also offering longer-term strategic value within active and consolidating mining districts. HighlightsAcquisition of high-grade, multi-asset exploration...

Continue reading

Malibu Boats, Inc. Accelerates Its Global Expansion with the Acquisition of Category Disruptor Saxdor Yachts, One of the World’s Fastest-Growing Boat Brands

Award-Winning Scandinavian Innovator is Redefining Premium Boating Establishes MBI’s Global Platform with Scalable European Operations and a Rapidly Expanding International Dealer Network Fills Strategic Whitespace in MBI’s Portfolio with Premium Adventure Dayboats – a $2.5 Billion Market Growing 15% Annually Statement Acquisition Advances “Build, Innovate, and Grow” Strategy Outlined at September 2025 Investor Day Immediate, Significant Accretion to MBI Earnings Per Share LOUDON, Tenn., March 02, 2026 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) (“Malibu”, “MBI” or the “Company”), a leading designer, manufacturer, and marketer of a diverse range of recreational powerboats and marine-services, today announced that it has acquired Saxdor Yachts (“Saxdor”), a leading European designer and manufacturer of premium adventure...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.